Skip to content
MedsAcross

Medicine

Methscopolamine 5 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Methscopolamine 5 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Methscopolamine
Brand
Sold under the generic name
Strength
5 mg
Dosage form
Tablet
Route
Oral
Packs
60 tablets, 5 blister pack, 1000 tablets and 4 more
Manufacturers
Unichem LaboratoriesIndiaBreckenridge Pharmaceuticali3 PharmaceuticalsBryant Ranch PrepackPD-Rx Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A03BB03 Methscopolamine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 May 2012
Identifiers
RxCUI 403914, 314088DailyMed set ID 6b8ed187-d378-4c95-80e0-0d3558a7aa95, 14c0c030-e96d-4a5e-95ff-02dd78a46be3, 157c1cce-bceb-4c74-8aa0-d2be9952d8f9 +2NDC 72162-2472, 72319-030, 51991-192 +2Application ANDA200602, ANDA216786, ANDA040642

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
60 tablet in 1 bottle76385-101-60Unichem LaboratoriesIndia1 October 2013
60 tablet in 1 bottle51991-192-06Breckenridge Pharmaceutical21 May 2012
5 blister pack in 1 box / 12 tablet in 1 blister pack51991-192-60Breckenridge Pharmaceutical21 May 2012
60 tablet in 1 bottle72319-030-02i3 Pharmaceuticals18 December 2024
1000 tablet in 1 bottle72319-030-06i3 Pharmaceuticals18 December 2024
60 tablet in 1 bottle72162-2472-6Bryant Ranch Prepack13 March 2026
60 tablet in 1 bottle, plastic43063-741-60PD-Rx Pharmaceuticals1 February 2017

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 April 1953Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Methscopolamine

Clinical summary

Methscopolamine is an anticholinergic. It is available as tablets for oral use. MedsAcross supplies Methscopolamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Methscopolamine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Methscopolamine 5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.